Japan Medical Dynamic Marketing, Inc.
7600.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.24 | -1.43 | -0.58 | 0.71 |
| FCF Yield | -3.36% | 1.57% | 3.17% | 3.53% |
| EV / EBITDA | 10.76 | 5.63 | 7.92 | 10.09 |
| Quality | ||||
| ROIC | 7.20% | 4.86% | 6.11% | 8.28% |
| Gross Margin | 62.30% | 63.69% | 65.67% | 67.67% |
| Cash Conversion Ratio | -2.27 | 1.29 | 1.24 | 1.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.63% | 6.49% | 8.38% | 2.01% |
| Free Cash Flow Growth | -266.67% | -65.26% | -42.97% | 24.34% |
| Safety | ||||
| Net Debt / EBITDA | 0.07 | -0.25 | -0.28 | -0.18 |
| Interest Coverage | 20.65 | 54.97 | 111.58 | 89.61 |
| Efficiency | ||||
| Inventory Turnover | 0.68 | 0.64 | 0.63 | 0.61 |
| Cash Conversion Cycle | 573.09 | 600.08 | 620.46 | 646.80 |